The use of 5α-reductase inhibitors for the prevention and treatment of prostate cancer

Eur Urol. 2011 Apr;59(4):515-7. doi: 10.1016/j.eururo.2011.01.028. Epub 2011 Jan 25.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Cholestenone 5 alpha-Reductase / antagonists & inhibitors*
  • Enzyme Inhibitors / therapeutic use*
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / prevention & control*

Substances

  • Enzyme Inhibitors
  • Cholestenone 5 alpha-Reductase